Cargando…

Proteasome inhibition—a new target for brain tumours

Detalles Bibliográficos
Autores principales:	Rashid, Fatima, Niklison-Chirou, Maria Victoria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892786/ https://www.ncbi.nlm.nih.gov/pubmed/31815002 http://dx.doi.org/10.1038/s41420-019-0227-x

Ejemplares similares

Glutamine metabolism, the Achilles heel for medulloblastoma tumor
por: Niklison-Chirou, Maria Victoria
Publicado: (2018)

Regulation of Adult Neurogenesis in Mammalian Brain
por: Niklison-Chirou, Maria Victoria, et al.
Publicado: (2020)

The role of immunomodulators in treatment-resistant depression: case studies
por: Beckett, Charles W., et al.
Publicado: (2022)

NPI-0052 and γ-radiation induce a synergistic apoptotic effect in medulloblastoma
por: Frisira, Eleni, et al.
Publicado: (2019)

National brain tumour registry: a new era of research collaboration with China
por: Valvi, Santosh, et al.
Publicado: (2023)

Can small molecular inhibitors that stop de novo serine synthesis be used in cancer treatment?
por: McNamee, Megan Jessica, et al.
Publicado: (2021)

Role of MicroRNAs in the Development and Progression of the Four Medulloblastoma Subgroups
por: Bevacqua, Emilia, et al.
Publicado: (2021)

Alcohol-abuse drug disulfiram targets pediatric glioma via MLL degradation
por: Meier, Stefanie, et al.
Publicado: (2021)

T-cell tumour exclusion and immunotherapy resistance: a role for CAF targeting
por: Hanley, Christopher J., et al.
Publicado: (2020)

Precision radiogenomics: fusion biopsies to target tumour habitats in vivo
por: Crispin-Ortuzar, Mireia, et al.
Publicado: (2021)

TAp73 promotes anti-senescence-anabolism not proliferation
por: Agostini, Massimiliano, et al.
Publicado: (2014)

Speaking up for the lost voices: representation and inclusion of people with communication impairment in brain tumour research
por: Menger, Fiona, et al.
Publicado: (2023)

Brain Leukocytes as the Potential Therapeutic Target for Post-COVID-19 Brain Fog
por: Kazama, Itsuro
Publicado: (2023)

Tumour-agnostic drugs in paediatric cancers
por: Chisholm, Julia C., et al.
Publicado: (2020)

Apoptotic mitochondria prime anti-tumour immunity
por: McArthur, Kate, et al.
Publicado: (2020)

BTK: a two-faced effector in cancer and tumour suppression
por: Rada, Miran, et al.
Publicado: (2018)

The C terminus of p73 is essential for hippocampal development
por: Amelio, Ivano, et al.
Publicado: (2020)

Enhancing preparedness for tackling new epidemic threats
por: Zumla, Alimuddin, et al.
Publicado: (2017)

Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
por: Feldmann, Marc, et al.
Publicado: (2020)

Complement C5a inhibition: a new form of COVID-19 treatment for mechanically ventilated patients?
por: Kalil, Andre C, et al.
Publicado: (2022)

Microglia have a grip on brain microvasculature
por: Kisler, Kassandra, et al.
Publicado: (2021)

Neutrophil Extracellular Traps (NETs): A New Therapeutic Target for Neuroinflammation and Microthrombosis After Subarachnoid Hemorrhage?
por: Zhou, Jiru, et al.
Publicado: (2022)

Cystic Fibrosis, New Frontier: Exploring the Functional Connectivity of the Brain Default Mode Network. Comment on Elce et al. Impact of Physical Activity on Cognitive Functions: A New Field for Research and Management of Cystic Fibrosis. Diagnostics 2020, 10, 489
por: Gambazza, Simone, et al.
Publicado: (2021)

The host response in different aetiologies of community-acquired pneumonia: Potential new targets for adjunctive treatments?
por: Vestergaard Jensen, Andreas
Publicado: (2022)

Holey barrier: claudins and the regulation of brain endothelial permeability
por: Matter, Karl, et al.
Publicado: (2003)

Two contrasting papers stimulate a commentary on the origins of tumour immunology, current cancer immunotherapies, and the future potential for cancer immunotherapy
por: Bodmer, Walter
Publicado: (2022)

Nonrandomised controlled trial in recurrent glioblastoma patients: the promise of autologous tumour lysate-loaded dendritic cell vaccination
por: Pasqualetti, Francesco, et al.
Publicado: (2023)

XVIIth Little Brain Big Brain: an extraordinary meeting in extraordinary times
por: Alcaino, Constanza, et al.
Publicado: (2023)

Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours
por: Oosting, Sjoukje F, et al.
Publicado: (2022)

Targeting Muscles in the Brain to Enhance Cerebral Perfusion
por: Lee, Jin-Moo, et al.
Publicado: (2019)

ELL targets c-Myc for proteasomal degradation and suppresses tumour growth
por: Chen, Yu, et al.
Publicado: (2016)

Mpox: a new name for a new disease?
por: Beaumont, Anne-Lise, et al.
Publicado: (2023)

Beliefs and desires in the predictive brain
por: Yon, Daniel, et al.
Publicado: (2020)

Plugging the medical brain drain
por: Kamarulzaman, Adeeba, et al.
Publicado: (2022)

The brain’s unique take on algorithms
por: Aimone, James B., et al.
Publicado: (2023)

Insulin-Degrading Enzyme Is a Non Proteasomal Target of Carfilzomib and Affects the 20S Proteasome Inhibition by the Drug
por: Tundo, Grazia Raffaella, et al.
Publicado: (2022)

Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma
por: Freire-Benéitez, Verónica, et al.
Publicado: (2021)

Correction to ‘Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma’
por: Freire-Benéitez, Verónica, et al.
Publicado: (2021)

Towards brain-tissue-like biomaterials
por: Axpe, Eneko, et al.
Publicado: (2020)

RAGE regulates oxytocin transport into the brain
por: Yamamoto, Yasuhiko, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vmjlan4nf4odrqggabrjfpmksj